Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38).
about
A Targeting Microbubble for Ultrasound Molecular ImagingThe Use of Acoustic Radiation Force Decorrelation-Weighted Pulse Inversion for Enhanced Ultrasound Contrast Imaging.Optical Verification of Microbubble Response to Acoustic Radiation Force in Large Vessels With In Vivo ResultsUltrasound-based measurement of molecular marker concentration in large blood vessels: a feasibility study.Squamous Cell Carcinoma Xenografts: Use of VEGFR2-targeted Microbubbles for Combined Functional and Molecular US to Monitor Antiangiogenic Therapy Effects.Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation.Ultrasound molecular imaging: Moving toward clinical translationQuantitative assessment of cancer vascular architecture by skeletonization of high-resolution 3-D contrast-enhanced ultrasound images: role of liposomes and microbubblesUltrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model.Recent developments in dynamic contrast-enhanced ultrasound imaging of tumor angiogenesis.Nanoparticles for imaging: top or flop?Assessment of the biodistribution of an [(18) F]FDG-loaded perfluorocarbon double emulsion using dynamic micro-PET in rats.The Theranostic Path to Personalized NanomedicineAn animal model allowing controlled receptor expression for molecular ultrasound imaging.Fast microbubble dwell-time based ultrasonic molecular imaging approach for quantification and monitoring of angiogenesis in cancer.Intravascular targets for molecular contrast-enhanced ultrasound imagingIn situ validation of VEGFR-2 and α v ß 3 integrin as targets for breast lesion characterization.Targeted antiangiogenesis gene therapy using targeted cationic microbubbles conjugated with CD105 antibody compared with untargeted cationic and neutral microbubblesUltrasound molecular imaging of tumor angiogenesis with a neuropilin-1-targeted microbubble.Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular ImagingEarlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model.Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.Applications of nanoparticles for diagnosis and therapy of cancer.Low-Dose Molecular Ultrasound Imaging with E-Selectin-Targeted PBCA Microbubbles.Status and trends in the development of clinical diagnostic agents.Quantification in molecular ultrasound imaging: a comparative study in mice between healthy liver and a human hepatocellular carcinoma xenograft.Nilotinib Enhances Tumor Angiogenesis and Counteracts VEGFR2 Blockade in an Orthotopic Breast Cancer Xenograft Model with Desmoplastic Response.Development and validation of an intrinsic landmark-based gating protocol applicable for functional and molecular ultrasound imaging.Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy.Targeting of microbubbles: contrast agents for ultrasound molecular imaging.The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55).Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results.Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo; therapeutic and chemopreventive applications.Preparation and Imaging Investigation of Dual-targeted C3F8-filled PLGA Nanobubbles as a Novel Ultrasound Contrast Agent for Breast Cancer.Improved Sensitivity in Ultrasound Molecular Imaging With Coherence-Based Beamforming
P2860
Q27304629-9F9004AB-A103-4288-B060-02A1CC152419Q30276184-0ECF5466-ED2F-4CF9-BF56-078DE025F5E8Q30279077-86121816-942C-486C-BF5C-313D2B6FF2F2Q30303105-5BE34D13-3E6A-42A3-9A97-DC70B375106AQ30357817-6D56213D-AE4F-4D36-9E1B-23D9CF7B867CQ30365404-C370CD92-22D7-4CF5-B48B-1FB90D682AF4Q30375187-0146850C-9A3E-4C99-BF78-3FEDBCC9BB11Q30400959-CFF09CE4-5BF8-469B-8D81-2687D781637DQ30417587-09984DA1-C48E-445F-953F-AF674C9F8B2DQ30419728-8101834C-89F2-4A14-B372-8455F93FA496Q30429119-0CBE4C36-C909-4FC9-993B-CD1D1FB833F6Q30435595-710545AB-BFD0-4AC6-A8B2-CF943FD5DCA8Q30437998-1B030FF4-4BD6-4418-A347-6BADA0919BB9Q30458500-A67D8C3A-3C25-422E-A819-C046EDD98FECQ30464428-0B0547DB-A4DC-44B2-8901-B4881B687FD7Q30465487-5AE85D27-5BE4-4DA4-848B-124ABF820C4CQ33687901-84F66B85-7212-4A39-BD86-2B67FBBC102AQ35086518-2374A4C4-15CB-4DFA-97D0-AE73DA3611E8Q35563176-BBE508BA-99B3-40E0-947F-5BB1F9F42991Q35751840-3C650B86-C749-4335-B374-B526132D0DBBQ36699083-AEDD06EB-FE44-4AE3-ADEF-88723BB180F4Q37616769-B05DB122-0F03-44D6-895A-DEB12B85F7ECQ38477152-FAA093CA-C800-4CDB-A1FA-3CA710D2DFD7Q38833728-948B7FC4-8FD7-4813-8C57-322EBC8FA3DDQ38995734-B2017A86-4006-4D79-8D17-0986C86D79EEQ39235504-0C470D5F-F809-4600-AB30-B9286E557215Q41667212-574D2A9B-157C-470F-9C4C-81B6CCD84C96Q43553930-72194EC5-CED0-473E-9F8F-94EF5BB153E0Q47140332-0A924B1E-F869-45C5-B634-FE74FD50A603Q47234214-F9F01A15-2F9A-4318-B375-5B77E907F96BQ47283269-B5F39325-AA78-4890-B95D-09BD3A7BDD65Q49774225-F76E2011-24E6-4814-A8C7-BBB8F18AA152Q49775755-B672689C-AAA1-4080-AF21-7D2F77360806Q52678263-ABAAF95E-DFD3-4FE6-8FCE-BD4AC6D6C4ACQ57575147-96CC96BE-2E84-459A-8910-768032A69F0B
P2860
Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Molecular and functional ultra ...... ntrast agents (BR55 and BR38).
@en
Molecular and functional ultra ...... vel ultrasound contrast agents
@nl
type
label
Molecular and functional ultra ...... ntrast agents (BR55 and BR38).
@en
Molecular and functional ultra ...... vel ultrasound contrast agents
@nl
prefLabel
Molecular and functional ultra ...... ntrast agents (BR55 and BR38).
@en
Molecular and functional ultra ...... vel ultrasound contrast agents
@nl
P2093
P2860
P1433
P1476
Molecular and functional ultra ...... ntrast agents (BR55 and BR38).
@en
P2093
Christoph Grouls
Fabian Kiessling
Isabelle Tardy
Jessica Bzyl
Michel Schneider
Monica Siepmann
Moritz Palmowski
Sibylle Pochon
Wiltrud Lederle
P2860
P2888
P304
P356
10.1007/S00330-011-2138-Y
P407
P577
2011-05-12T00:00:00Z